Merck and Bristol-Myers Squibb are key players in cancer treatment. Find out why MRK and BMY stocks have different prospects ...

Bayer was ordered to pay more than $2 billion by a jury in a Georgia state court in the latest legal case surrounding alleged ...

POOR PIERRE — Mere months ago, the Conservative Party in Canada looked headed towards a landslide victory. Its leader, Pierre Poilievre, was ascendant and drawing rave reviews from much of the ...

(RTTNews) - The Hong Kong stock market has moved lower in consecutive ... CNOOC advanced 0.91 percent, CSPC Pharmaceutical sank 1.24 percent, Galaxy Entertainment shed 1.23 percent, Hang Lung ...

Canada and the European Union swiftly unveil retaliatory levies against the U.S., hours after Trump's sweeping tariffs on ...

In an unprecedented event — part news conference, part infomercial — President Trump showcased Tesla vehicles on a White ...

Major AI stocks are struggling to gain traction as investors rethink their strategies amid concerns of a slowdown in spending.

FSGS attacks the kidneys and results in irreversible scarring, leading to permanent kidney damage and eventually ... deal in October 2023 with Advanz Pharma covering the European Economic Area ...

Get the latest market news, interviews and stock alerts. Small Caps is Australia's #1 site for market news & information on ASX listed small cap companies. Small Caps and affiliated companies accept ...

Cramer stated on Mad Money at the end of last week's trading that Recursion's stock performance has "been disastrous" since the company's management appeared on his program in May 2024. He added, ...

However, the stock was also likely negatively impacted by CNBC Mad Money host Jim Cramer's comments on Friday. He expressed reservations about buying shares of Recursion Pharmaceuticals in light ...